Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CaM V Inhibitors

The chemical class of CaM V inhibitors encompasses a diverse range of compounds designed to modulate the activity of Calmodulin V (CaM V), a multifunctional protein crucial for various cellular processes. CaM V is involved in calcium ion binding activity, myosin V binding activity, and myosin VI head/neck binding activity, playing a pivotal role in metarhodopsin inactivation, neuron development, and the regulation of ion transmembrane transporter activity. This intricate interplay of functions occurs in various cellular components, including the microtubule cytoskeleton, midbody, and rhabdomere, with specific involvement in myosin V, VI, and VII complexes. One class of inhibitors, exemplified by Ethylene Glycol, disrupts CaM V by interfering with its calcium ion binding activity. This alteration influences the regulation of ion transmembrane transporter activity, impacting CaM V's function within the plasma membrane.

Ruthenium Red acts as a direct inhibitor, disrupting myosin VI head/neck binding activity, leading to altered regulation of ion transmembrane transporter activity. This influences CaM V within the myosin VI complex and impacts its function in the microtubule cytoskeleton. Oxalyl Chloride interferes with CaM V's calcium ion binding, affecting metarhodopsin inactivation, myosin V complex, and the regulation of ion transmembrane transporter activity within the microtubule cytoskeleton. MG-132, an inhibitor targeting ubiquitin-proteasome systems, modulates CaM V through its impact on the myosin VI complex, affecting metarhodopsin inactivation and ion transmembrane transporter activity regulation. EDTA chelates calcium ions, disrupting CaM V's calcium binding activity and influencing neuron development within the plasma membrane. Tunicamycin, an indirect inhibitor affecting N-glycosylation, influences CaM V through neuron development processes within the myosin VI complex and impacts the regulation of ion transmembrane transporter activity. Dithiothreitol (DTT), a disulfide bond disruptor, indirectly inhibits CaM V, influencing the regulation of ion transmembrane transporter activity within the microtubule cytoskeleton.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ethylene glycol

107-21-1sc-257515
sc-257515A
500 ml
1 L
$85.00
$120.00
1
(1)

Inhibits CaM V by disrupting its calcium ion binding activity. Alters the regulation of ion transmembrane transporter activity, impacting CaM V function in cellular components like the plasma membrane.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Indirect inhibitor targeting myosin V binding activity. Modulates metarhodopsin inactivation, influencing CaM V through neuron development processes. Alters the cellular localization, hindering CaM V within the microtubule cytoskeleton.

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

Inhibits CaM V through myosin VI head/neck binding activity disruption. Impacts the myosin VI complex, leading to altered regulation of ion transmembrane transporter activity and affecting CaM V function.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Inhibits CaM V through ubiquitin-proteasome system disruption. Modulates myosin VI complex, influencing metarhodopsin inactivation, and regulates ion transmembrane transporter activity. Impacts CaM V localization, hindering its function.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Indirect inhibitor affecting N-glycosylation, influencing CaM V through neuron development processes. Alters myosin VI complex, leading to the regulation of ion transmembrane transporter activity and impacting CaM V function.

Glycerol

56-81-5sc-29095A
sc-29095
100 ml
1 L
$56.00
$153.00
12
(5)

Modifies cellular osmolarity, indirectly impacting CaM V through altered regulation of ion transmembrane transporter activity. Alters myosin V complex, influencing CaM V function in the plasma membrane.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Inhibits CaM V through Hsp90 chaperone disruption. Modulates myosin VI complex, influencing neuron development processes, and regulates ion transmembrane transporter activity. Alters CaM V localization, hindering its function.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

Inhibits CaM V by modulating calcium ion signaling. Alters the regulation of ion transmembrane transporter activity, impacting CaM V function in the plasma membrane.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Indirect inhibitor targeting ubiquitin-dependent ERAD pathway associated with CaM V. Modulates neuron development processes, influencing CaM V through myosin V complex. Alters the microtubule cytoskeleton, hindering CaM V localization.